KAPA vs LYB · $18.8M cap vs P/E 21, rev $16.37B
Kairos Pharma, Ltd. (KAPA) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
KAPA does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
KAPA currently screens at market cap $18.8M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the KAPA and LYB stock pages for the full models.
Not investment advice.